Classification of Grades of Subchondral Sclerosis from Knee Radiographic Images Using Artificial Intelligence.

Journal: Sensors (Basel, Switzerland)
PMID:

Abstract

Osteoarthritis (OA) is the most common joint disease, affecting over 300 million people worldwide. Subchondral sclerosis is a key indicator of OA. Currently, the diagnosis of subchondral sclerosis is primarily based on radiographic images; however, reliability issues exist owing to subjective evaluations and inter-observer variability. This study proposes a novel diagnostic method that utilizes artificial intelligence (AI) to automatically classify the severity of subchondral sclerosis. A total of 4019 radiographic images of the knee were used to train the 3-Layer CNN, DenseNet121, MobileNetV2, and EfficientNetB0 models. The best-performing model was determined based on sensitivity, specificity, accuracy, and area under the curve (AUC). The proposed model exhibited outstanding performance, achieving 84.27 ± 1.03% sensitivity, 92.46 ± 0.49% specificity, 84.70 ± 0.98% accuracy, and 95.17 ± 0.41% AUC. The analysis of variance confirmed significant performance differences across models, age groups, and sexes ( < 0.05). These findings demonstrate the utility of AI in diagnosing and treating knee subchondral sclerosis and suggest that this approach could provide a new diagnostic method in clinical medicine. By precisely classifying the grades of subchondral sclerosis, this method contributes to improved overall diagnostic accuracy and offers valuable insights for clinical decision-making.

Authors

  • Soo-Been Kim
    Medical Devices R&D Center, Gil Medical Center, Gachon University, Incheon 21565, Republic of Korea.
  • Young Jae Kim
    Department of Biomedical Engineering, College of Medicine, Gachon University, Gyeonggi-do, Republic of Korea.
  • Joon-Yong Jung
    Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. messengr@catholic.ac.kr.
  • Kwang Gi Kim
    Department of Biomedical Engineering Branch, National Cancer Center, Gyeonggi-do, South Korea.